SCD1 inhibition promotes lipid peroxidation and enhances anti-PD-1 response in triple-negative breast cancer
BackgroundTriple-negative breast cancer (TNBC) is a heterogeneous disease that often exhibits a relatively immunologically “cold” tumor microenvironment, which can limit the efficacy of immune checkpoint inhibitors (ICIs). Alterations in lipid metaboli…